These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1614763)

  • 21. [Can we control pertussis better? II. Old and new vaccines against pertussis].
    Gałazka A
    Przegl Epidemiol; 1997; 51(3):285-95. PubMed ID: 9411499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Time for booster doses against whooping cough for 10-year-old children].
    Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
    Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination.
    Olin P; Hallander HO; Gustafsson L; Barreto L; Podda A
    Dev Biol Stand; 1998; 95():211-20. PubMed ID: 9855434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of currently available Japanese acellular pertussis vaccines and future problems.
    Kamiya H; Nii R
    Tokai J Exp Clin Med; 1988; 13 Suppl():45-9. PubMed ID: 3273618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American Academy of Pediatrics Committee on Infectious Diseases: The status of acellular pertussis vaccines: current perspective.
    Pediatrics; 1991 Aug; 88(2):401-5. PubMed ID: 1861950
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA approval of a Haemophilus b Conjugate Vaccine combined by reconstitution with an acellular pertussis vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(45):993-5. PubMed ID: 9005308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An adolescent-adult formulation tetanus and diptheria toxoids adsorbed combined with acellular pertussis vaccine has comparable immunogenicity but less reactogenicity in children 4-6 years of age than a pediatric formulation acellular pertussis vaccine and diphtheria and tetanus toxoids adsorbed combined with inactivated poliomyelitis vaccine.
    Langley JM; Predy G; Guasparini R; Law B; Diaz-Mitoma F; Whitstitt P; Tapiero B; Dionne M; Tomovici A; Mills E; Halperin SA
    Vaccine; 2007 Jan; 25(6):1121-5. PubMed ID: 17045366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recommended childhood immunization schedule--United States, July-December 1996. Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the Food and Drug Administration (FDA).
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(29):635-8. PubMed ID: 8965793
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pertussis immunization in children with neurological illnesses.
    Sundaresan CR
    Indian Pediatr; 2000 Feb; 37(2):209-10. PubMed ID: 10745422
    [No Abstract]   [Full Text] [Related]  

  • 32. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Immunization Practices Advisory Committee.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jul; 34(27):405-14, 419-26. PubMed ID: 3925316
    [No Abstract]   [Full Text] [Related]  

  • 33. National Advisory Committee on Immunization (NACI). Statement on pertussis immunization.
    Can Commun Dis Rep; 1993 Mar; 19(6):41-5. PubMed ID: 8481708
    [No Abstract]   [Full Text] [Related]  

  • 34. Adolescent and adult pertussis: disease burden and prevention.
    Edwards K; Freeman DM
    Curr Opin Pediatr; 2006 Feb; 18(1):77-80. PubMed ID: 16470167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
    Gustafsson L; Hessel L; Storsaeter J; Olin P
    Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles outbreak among unvaccinated preschool-aged children: opportunities missed by health care providers to administer measles vaccine.
    Hutchins SS; Escolan J; Markowitz LE; Hawkins C; Kimbler A; Morgan RA; Preblud SR; Orenstein WA
    Pediatrics; 1989 Mar; 83(3):369-74. PubMed ID: 2784000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of an increase in cardiorespiratory events after diphtheria-tetanus-acellular pertussis immunization in preterm infants: a randomized, multicenter study.
    Carbone T; McEntire B; Kissin D; Kelly D; Steinschneider A; Violaris K; Karamchandani N
    Pediatrics; 2008 May; 121(5):e1085-90. PubMed ID: 18450851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ACIP issues statement on acellular pertussis vaccine.
    Am Fam Physician; 1992 Jul; 46(1):286, 291. PubMed ID: 1621635
    [No Abstract]   [Full Text] [Related]  

  • 40. Pertussis vaccine.
    Shendurinikar N
    Indian Pediatr; 1989 Sep; 26(9):964-5. PubMed ID: 2634020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.